Search

Displaying results 881 - 890 of 10000 in total
  1. Drug

    Colchicine

    go.drugbank.com/drugs/DB01394
    ApprovedInvestigational

    [L47591] It has also been investigated in other inflammatory and fibrotic conditions.[A183602]

    Products: COLCHICINE TABLET 500 mcg, COLCHICINE TABLETS BP 500 mcg
  2. Drug

    Lomitapide

    go.drugbank.com/drugs/DB08827
    Approved

    Lomitapide, marketed under the brand names Juxtapid (USA) and Lojuxta (EU), is a first-in-class, small-molecule inhibitor of microsomal triglyceride transfer protein (MTP). … [A275445, A7367] This makes it a critical therapeutic option for "receptor-negative" patients who have little to no functional LDL receptor activity.

    Products: JUXTAPID® CÁPSULAS POR 20 MG, JUXTAPID CAPSULAS POR 10 MG
  3. Drug

    Tenofovir disoproxil

    go.drugbank.com/drugs/DB00300
    ApprovedInvestigational

    Tenofovir disoproxil was initially approved in 2001 [FDA label].

    Mixtures: FORSTAVIR-LE ( Efavirenz 600 mg, Lamivudine 300 mg and Tenofovir Disoproxil Fumarate 300 mg ) Film-coated Tablets, TENOHOPE E (EMTRICITABINE 200 MG & TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS)Products: TENARTA 300 MG, VIRKIL FILM-COATED TABLETS 300 MG
  4. Drug

    Brimonidine

    go.drugbank.com/drugs/DB00484
    ApprovedInvestigational

    [A178951] It is considered to be a third generation alpha-2 aadrenergic receptor agonist, since it displays preferential binding at alpha-2 adrenoceptors over alpha-1 receptors. … Early treatment and management of glaucoma, which predominantly involves the lowering of intraocular pressure, is critical since glaucoma is considered to be a common cause of blindness worldwide.

    Mixtures: SIMBRINZA EYE DROPS, SUSPENSION 10 MG/ML + 2 MG/ML, SİMBRİNZA 10 MG/ML + 2 MG/ML GÖZ DAMLASI, SÜSPANSİYON, 5 MLProducts: BRIMONIDINA EG, BRIMOLAG® TARTRATO DE BRIMONIDINA 2MG/ML SOLUCION OFTALMICA.
  5. Drug

    Betamethasone

    go.drugbank.com/drugs/DB00443
    ApprovedInvestigationalVet approved

    [A192444] It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders.

    Mixtures: BRUMETON 1 MG/ML+100 MG/ML GÖZ DAMLASI, Fusicutan 20 mg/g + 1 mg/g CremeProducts: NOVOVATE LOSYON, 20 ML, BETNOVATE LOSYON, 20 ML
  6. Drug

    Entecavir

    go.drugbank.com/drugs/DB00442
    ApprovedInvestigational

    It was approved by the U.S. Food and Drug Administration (FDA) in March 2005. … It is marketed under the trade name Baraclude (BMS).

    Products: VORIX® 1.0 MG, HEPAGARD 0.05 MG/ML ORAL ÇÖZELTI ,240 ML
  7. Drug

    Insulin detemir

    go.drugbank.com/drugs/DB01307
    ApprovedInvestigational

    [A2358, A2359, A2360, A44] This insulin analogue has a 14-C fatty acid, myristic acid, bound to the lysine amino acid at position B29. … [A2358, A2359, A2360, A44] Marketed as the brand name product Levemir, insulin detemir has a duration of action of 16-24 hours allowing for once-daily dosing, typically at bedtime.

    Products: 100 U/ML, Levemir® FlexPen® 100 U/ml Solution for Injection in Pre-filled Pen
  8. Drug

    Anagrelide

    go.drugbank.com/drugs/DB00261
    ApprovedInvestigational

    [busulfan], [hydroxyurea]) and may be better tolerated.[A214274] … [L14153] It is an oral imidazoquinazoline that was first approved for use in the US in 1997.[A214274] It appears to carry a better response rate than other thrombocythemia treatments (e.g.

    Products: ANAGLYN 0,5 MG SERT KAPSÜL, 100 KAPSÜL, GRAFTA 0.5 MG SERT KAPSÜL, 100 ADET
  9. Drug

    Calfactant

    go.drugbank.com/drugs/DB06415
    ApprovedInvestigational

    Each milliliter of calfactant contains 35mg of phospholipids (including 26 mg phosphatidylcholine of which 16 mg is disaturated phosphatidylcholine) and 0.65mg of proteins including surfactant-associated … It is an off-white suspension of an extract of natural surfactant from calf lungs suspended in 0.9% saline.

    Products: INFASURF 35 MG/ML INTRATRAKEAL SÜSPANSIYON ,6 ML, INFASURF 35 MG/ML INTRATRAKEAL SÜSPANSIYON,3 ML
  10. Drug

    Atosiban

    go.drugbank.com/drugs/DB09059
    ApprovedInvestigational

    It is used intravenously to halt premature labor. Although initial studies suggested it could be used as a nasal spray and hence would not require hospital admission, it is not used in that form. … It was first reported in the literature in 1985. Atosiban is licensed in proprietary and generic forms for the delay of imminent pre-term birth in pregnant adult women.

    Products: Atosiban EVER Pharma 75 mg/10 ml Konzentrat zur Herstellung einer Infusionslösung, Atosiban Aguettant 6,75 mg/0,9 ml Injektionslösung